Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Benzinga Insights

Veracyte's Return On Capital Employed Insights

According to Benzinga Pro data, during Q4, Veracyte (NASDAQ:VCYT) posted sales of $67.34 million. Earnings were up 25.49%, but Veracyte still reported an overall loss of $10.53 million. In Q3, Veracyte brought in $60.37 million in sales but lost $14.13 million in earnings.

Why Is ROCE Significant?

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.